Cumberland Pharmaceuticals's total assets for Q3 2025 were $65.90M, a decrease of -2.96% from the previous quarter. CPIX total liabilities were $40.10M for the fiscal quarter, a -0.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.